Klein M S, Ludbrook P A, Mimbs J W, Gafford F H, Gillespei T A, Weldon C S, Sobel B E, Roberts R
J Thorac Cardiovasc Surg. 1977 Feb;73(2):253-7.
Coronary bypass surgery may be associated with an increased perioperative mortality rate in patients with unstable compared to stable angina. The mortality rate is excessively high when surgery is performed during evolving myocardial infarction. Elevated plasma MB CPK isoenzyme activity is a remarkably sensitive and specific marker of myocardial damage. Accordingly, we studied 111 patients with unstable angina to determine whether exclusion of patients with initially elevated MB CPK improves the perioperative mortality rate. Plasma MB CPK activity was assayed prior to catheterization and every 2 hours therafter. Of the 111 patients, 16, with initially elevated MB CPK activity, were excluded and managed medically. Catheterization was performed in 59 patients, and severe vessel obstruction was documented in 55. Coronary bypass surgery performed in 47 patients was associated with a mortality rate of 4 per cent. Thus, after exclusion of patients with evolving infarction by MB CPK isoenzyme analysis, catheterization and coronary bypass surgery in patients with unstable angina resulted in a mortality rate comparable to that in patients with stable angina.
与稳定型心绞痛患者相比,不稳定型心绞痛患者进行冠状动脉搭桥手术可能会增加围手术期死亡率。在进展性心肌梗死期间进行手术时,死亡率过高。血浆肌酸磷酸激酶MB同工酶活性升高是心肌损伤非常敏感和特异的标志物。因此,我们研究了111例不稳定型心绞痛患者,以确定排除最初MB肌酸磷酸激酶升高的患者是否能提高围手术期死亡率。在导管插入术前及之后每2小时检测一次血浆MB肌酸磷酸激酶活性。111例患者中,16例最初MB肌酸磷酸激酶活性升高,被排除并接受药物治疗。59例患者进行了导管插入术,其中55例记录有严重血管阻塞。47例患者接受冠状动脉搭桥手术,死亡率为4%。因此,通过MB肌酸磷酸激酶同工酶分析排除进展性梗死患者后,不稳定型心绞痛患者进行导管插入术和冠状动脉搭桥手术的死亡率与稳定型心绞痛患者相当。